CXCL10 increases the proliferation of mouse breast cancer stem cells and breast cancer cells, and is significantly associated with triple negative breast cancer versus HER2+, Luminal A and Luminal B breast cancer [55]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.